Anticancer Res 21: 24572461
Urolithiasis 43(Suppl 1):93107
Semax is considered investigational in the United States and is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease
While a significant increase in KLK-3 levels can be concerning, it is not definitive for diagnosing prostate cancer, as various benign conditions can also cause KLK-3 elevation, However, Naringin treatment attenuated the surge in KLK3 levels, suggesting its role in modulating inflammatory responses and proteolytic activity
Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment
But the excitement for peptides, including BPC-157, is very premature: For one thing, the evidence that proponents rave about comes from animal data, not human studies